Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Insignia Systems Inc

Start price
Target price
Perf. (%)
€0.76
22.10.22
€1.00
-
04.01.21

buy
Waste Management Inc.

Start price
Target price
Perf. (%)
€162.68
20.10.22
-
01.01.25
24.50%
28.06.24

buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€216.15
19.10.22
€395.00
17.09.24
92.23%
28.06.24

buy
TeamViewer AG

Start price
Target price
Perf. (%)
€8.75
19.10.22
€20.00
19.10.24
19.26%
28.06.24

Could be very worthwhile Investment >20% year
Future proof or reliable business model
Well known brand
Small cyclical dependencies
buy
Siemens Energy AG

Start price
Target price
Perf. (%)
€11.35
19.10.22
€25.00
19.10.24
114.01%
28.06.24

Could be very worthwhile Investment >20% year
Well known brand
Future proof or reliable business model
buy
Biomerieux

Start price
Target price
Perf. (%)
€9.00
18.10.22
€11.00
-
09.06.22

buy
Cameco Corp.

Start price
Target price
Perf. (%)
€23.13
12.10.22
€62.00
12.01.27
99.08%
28.06.24

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Very Future proof/growth oriented business model
buy
Biohaven Pharmac.hldg Co.ltd.

Start price
Target price
Perf. (%)
€156.00
11.10.22
€160.00
-
03.10.22

buy
Nemaura Medical Inc

Start price
Target price
Perf. (%)
€0.51
08.10.22
€0.80
-
05.12.19

buy
Domino's Pizza Inc.

Start price
Target price
Perf. (%)
€337.40
23.09.22
€400.00
27.08.24
44.97%
28.06.24

buy
Ferrexpo plc

Start price
Target price
Perf. (%)
€1.71
15.09.22
-
08.09.26
-68.67%
27.06.24

buy
Vale S.A.

Start price
Target price
Perf. (%)
€12.90
08.09.22
€16.00
08.09.26
-5.08%
28.06.24

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
Probably not worthwhile Investment
buy
Ocular Therapeutix Inc.

Start price
Target price
Perf. (%)
€5.70
07.09.22
€10.00
31.12.24
12.00%
28.06.24

Could be very worthwhile Investment >20% year
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€208.80
07.09.22
€300.00
31.12.24
8.67%
28.06.24

Could be very worthwhile Investment >20% year
buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€29.80
07.09.22
€50.00
31.12.25
13.42%
28.06.24

Could be very worthwhile Investment >20% year
buy
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€37.60
07.09.22
€50.00
31.12.24
-2.66%
28.06.24

Could be very worthwhile Investment >20% year
buy
Soltech Energy Sweden Ab

Start price
Target price
Perf. (%)
€1.53
05.09.22
-
29.08.26
-76.83%
27.06.24

Revenue growth >5% per year expected
Probably not worthwhile Investment
buy
Ceconomy AG VZO

Start price
Target price
Perf. (%)
€3.74
31.08.22
€5.00
-
31.05.22

buy
2G Energy AG

Start price
Target price
Perf. (%)
€24.40
30.08.22
-
28.12.25
-8.16%
28.06.24

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
High Investments for future growth
buy
Parker Drilling Co.

Start price
Target price
Perf. (%)
€4.02
26.08.22
€4.50
-
21.01.21

buy
Akasol AG

Start price
Target price
Perf. (%)
€120.00
26.08.22
€125.00
-
26.05.21

Matador Resources

Start price
Target price
Perf. (%)
€63.50
25.08.22
€38.00
25.08.24
-13.77%
21.06.24

Probably not worthwhile Investment
Low dividend yield expected
overvalued
Higher risks for its business
buy
GW Pharmaceuticals plc ADR

Start price
Target price
Perf. (%)
€183.00
25.08.22
-
-
04.05.21

buy
CannaRoyalty Corp

Start price
Target price
Perf. (%)
€3.77
25.08.22
€5.00
-
08.01.20

buy
Cheniere Energy Partners

Start price
Target price
Perf. (%)
€26.92
23.08.22
€30.00
-
14.04.20